Back

No-reflow: prevention and pathophysiology - State of the art

26 August 2018 (14:30 - 14:47)
Organised by:
Congress Presentation Part of: No-reflow prevention and pathophysiology No Reflow ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Philip Wenzel

Johannes Gutenberg University Mainz (JGU), Mainz (Germany)

4 More presentations in this session

Presentation thumbnail
The modulation of miR-129-3p levels in coronary thrombi after primary PCI discloses a novel potential mechanism underlying the no reflow phenomenon
Doctor S. De Rosa (Catanzaro, IT)
Abstract
Presentation thumbnail
Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study
Doctor M. Farag (Newcastle Upon Tyne, GB)
Abstract Slides Video
Presentation thumbnail
Multicenter randomized clinical trial of the efficacy and safety of intravenous quercetin in patients with ST-elevation acute myocardial infarction
Doctor S. Kozhukhov (Kiev, UA)
Abstract
Presentation thumbnail
The future of preventing reperfusion injury: achievable anytime soon?
Doctor D. Pinto (Boston, US)
Slides Video

Access the full session

Session thumbnail
No-reflow prevention and pathophysiology

The Event

Event poster

ESC Congress 2018

26 August 2018 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Cardioprotective strategy in ST-elevation acute myocardial infarction patients after reperfusion with percutaneous coronary intervention
28 August 2020
thumbnail
Congress Presentation
Conclusion
26 August 2023
thumbnail
Congress Presentation
31 August 2019
thumbnail
Congress Presentation
Relevance of necroptosis in the hearts subjected to acute versus chronic ischemia/reperfusion injury
29 April 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources